Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

FTIR spectroscopic imaging and mapping with correcting lenses for studies of biological cells and tissues.

Kimber JA, Foreman L, Turner B, Rich P, Kazarian SG.

Faraday Discuss. 2016 Jun 23;187:69-85. doi: 10.1039/c5fd00158g.

PMID:
27056467
2.

Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.

Kimber J, Larney S, Hickman M, Randall D, Degenhardt L.

Lancet Psychiatry. 2015 Oct;2(10):901-8. doi: 10.1016/S2215-0366(15)00366-1.

PMID:
26384619
3.

The biocompatibility of carbon hydroxyapatite/β-glucan composite for bone tissue engineering studied with Raman and FTIR spectroscopic imaging.

Sroka-Bartnicka A, Kimber JA, Borkowski L, Pawlowska M, Polkowska I, Kalisz G, Belcarz A, Jozwiak K, Ginalska G, Kazarian SG.

Anal Bioanal Chem. 2015 Oct;407(25):7775-85. doi: 10.1007/s00216-015-8943-4.

PMID:
26277184
4.

Drug-related mortality in psychiatric patients.

Lynskey MT, Kimber J, Strang J.

Lancet Psychiatry. 2015 Sep;2(9):767-9. doi: 10.1016/S2215-0366(15)00372-7. No abstract available.

PMID:
26277045
5.

Imprisonment of opioid-dependent people in New South Wales, Australia, 2000–2012: a retrospective linkage study.

Degenhardt L, Larney S, Gisev N, Trevena J, Burns L, Kimber J, Shanahan M, Butler T, Mattick RP, Weatherburn D.

Aust N Z J Public Health. 2014 Apr;38(2):165-70.

PMID:
25874282
6.

A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.

Burns L, Gisev N, Larney S, Dobbins T, Gibson A, Kimber J, Larance B, Mattick RP, Butler T, Degenhardt L.

Addiction. 2015 Apr;110(4):646-55. doi: 10.1111/add.12834.

PMID:
25516077
7.

Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging.

Pudlas M, Kyeremateng SO, Williams LA, Kimber JA, van Lishaut H, Kazarian SG, Woehrle GH.

Eur J Pharm Sci. 2015 Jan 25;67:21-31. doi: 10.1016/j.ejps.2014.10.012.

PMID:
25445833
8.

Fast drying and film formation of latex dispersions studied with FTIR spectroscopic imaging.

Kimber JA, Gerst M, Kazarian SG.

Langmuir. 2014 Nov 18;30(45):13588-95. doi: 10.1021/la5035257.

PMID:
25343527
9.

Excess mortality among opioid-using patients treated with oral naltrexone in Australia.

Degenhardt L, Larney S, Kimber J, Farrell M, Hall W.

Drug Alcohol Rev. 2015 Jan;34(1):90-6. doi: 10.1111/dar.12205.

PMID:
25302627
10.

Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians.

Gisev N, Gibson A, Larney S, Kimber J, Williams M, Clifford A, Doyle M, Burns L, Butler T, Weatherburn DJ, Degenhardt L.

BMC Public Health. 2014 Sep 6;14:920. doi: 10.1186/1471-2458-14-920.

11.

A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.

Gisev N, Degenhardt L, Larney S, Larance B, Gibson A, Kimber J, Burns L.

Drug Alcohol Rev. 2014 Sep;33(5):499-505. doi: 10.1111/dar.12151.

PMID:
24840554
12.

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study.

Larney S, Gisev N, Farrell M, Dobbins T, Burns L, Gibson A, Kimber J, Degenhardt L.

BMJ Open. 2014 Apr 2;4(4):e004666. doi: 10.1136/bmjopen-2013-004666.

13.

The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.

Degenhardt L, Larney S, Kimber J, Gisev N, Farrell M, Dobbins T, Weatherburn DJ, Gibson A, Mattick R, Butler T, Burns L.

Addiction. 2014 Aug;109(8):1306-17. doi: 10.1111/add.12536.

PMID:
24612249
14.

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Mattick RP, Breen C, Kimber J, Davoli M.

Cochrane Database Syst Rev. 2014 Feb 6;(2):CD002207. doi: 10.1002/14651858.CD002207.pub4. Review.

PMID:
24500948
15.

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ.

Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Review.

PMID:
23973009
16.

Engagement with the criminal justice system among opioid-dependent people: a retrospective cohort study.

Degenhardt L, Gisev N, Trevena J, Larney S, Kimber J, Burns L, Shanahan M, Weatherburn D.

Addiction. 2013 Dec;108(12):2152-65. doi: 10.1111/add.12324.

PMID:
23941286
17.

Elasmobranch cognitive ability: using electroreceptive foraging behaviour to demonstrate learning, habituation and memory in a benthic shark.

Kimber JA, Sims DW, Bellamy PH, Gill AB.

Anim Cogn. 2014 Jan;17(1):55-65. doi: 10.1007/s10071-013-0637-8.

PMID:
23620366
18.

Early life influences on the risk of injecting drug use: case control study based on the Edinburgh Addiction Cohort.

Macleod J, Hickman M, Jones HE, Copeland L, McKenzie J, De Angelis D, Kimber J, Robertson JR.

Addiction. 2013 Apr;108(4):743-50. doi: 10.1111/add.12056.

PMID:
23163301
19.

Premature mortality in Scottish injecting drug users: a life-history approach.

Copeland L, Robertson J, McKenzie J, Kimber J, Macleod J, Hickman M, de Angelis D.

Scott Med J. 2012 Feb;57(1):38-42. doi: 10.1258/smj.2011.011289.

PMID:
22408214
20.

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.

Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, Robertson JR.

BMJ. 2010 Jul 1;341:c3172. doi: 10.1136/bmj.c3172.

Items per page

Supplemental Content

Loading ...
Support Center